dc.rights.license | Atribución-NoComercial-SinDerivadas 4.0 Internacional |
dc.contributor.advisor | Arias Guatibonza, Jaime Andelfo |
dc.contributor.author | Ramírez Grueso, Raúl |
dc.date.accessioned | 2021-01-28T18:04:10Z |
dc.date.available | 2021-01-28T18:04:10Z |
dc.date.issued | 2021 |
dc.identifier.citation | Ramírez, G. (2020). Caracterización de la expresión de receptores de progesterona en meningiomas intracraneales de pacientes tratados quirúrgicamente en una unidad de servicios de salud de alta complejidad en Bogotá – Colombia [Tesis de especialidad, Universidad Nacional de Colombia]. Repositorio Institucional. |
dc.identifier.uri | https://repositorio.unal.edu.co/handle/unal/78967 |
dc.description.abstract | BACKGROUND. Meningiomas are the single most common brain tumor. The incidence of these tumors increases with age; different studies have shown that meningiomas usually appear after the age of 50. These tumors are more common in women than in men, who are twice as likely to suffer from the condition. Surgery is the primary form of treatment, which can be curative with complete resection. If the tumor is unresectable or other treatments such as surgery and radiotherapy have failed, hormonal therapy or chemotherapy may be considered. There is limited information about the clinical, demographic, and histopathological characteristics of these tumors in the population of Bogotá, Colombia.
OBJECTIVE: To evaluate the expression of progesterone receptors in patients over 18 years old who have been diagnosed with meningiomas in a high-complexity hospital in Bogota, Colombia, and to describe the demographic and histopathological characteristics of these patients.
METHODS: This is a descriptive and retrospective case series. Patients with meningioma who underwent surgical resection at a high-complexity hospital in Bogota, Colombia, from 2016 to 2019 were retrospectively identified and studied. Demographic variables, such as age and gender, were extracted from the clinical chart. Indirect immunoperoxidase staining was carried out for PR (progesterone receptor) and Ki67. PR is analyzed as positive and negative, and Ki67 proliferation index was determined.
RESULTS: 32 meningiomas from patients who underwent surgery were available for analysis. 25 (78.1%) were positive to PR. 71.8% were females, and 93% were World Health Organization (WHO) grade I. Meningothelial (28%), fibrous (25%), and transitional (25%) were the most frequent subtypes, correspondingly. Ki67 mean value was 1.14 (0.11-10.71).
CONCLUSION: Our case series showed a greater frequency of meningiomas in women, with a high progesterone receptor expression and a low Ki67 proliferation rate. This data correlates with literature worldwide. |
dc.description.abstract | INTRODUCCIÓN. Los meningiomas son el tumores cerebrales más comunes. Su incidencia aumenta con la edad, alcanza el pico después de la quinta década de la vida y afecta más comúnmente a las mujeres que a los hombres. El tratamiento principal para los meningiomas es la cirugía, la cual puede ser curativa si el tumor es resecado por completo. Cuando el meningioma es irresecable u otros tratamientos, como la cirugía y la radioterapia, han fallado, la terapia hormonal o la quimioterapia podrían ser considerados. Existe información limitada sobre la distribución y las características histopatológicas de estos tumores en nuestra población.
OBJETIVO: Evaluar la expresión de receptores de progesterona (PR) en pacientes mayores de 18 años diagnosticados con meningiomas en un hospital de Bogotá, Colombia, y describir las características clínicas, demográficas e histopatológicas de estos pacientes.
MÉTODOS: Se identificaron pacientes con diagnostico de meningioma intracraneal que fueron sometidos a resección quirúrgica en nuestra institución de 2016 a 2019 y se estudiaron retrospectivamente. Se extrajeron de la historia clinica variables demográficas, como la edad y el sexo. Se llevó a cabo una tinción con inmunoperoxidasa indirecta para PR y Ki67. El PR se analiza como positivo y negativo y el índice de proliferación ki67 fue determinado.
RESULTADOS: El rendimiento de la busqueda feron 32 meningiomas de pacientes que fueron llevados a cirugía y se contaban con datos clinicos completos para su análisis. De estos, 25 fueron positivos para el receptor de progesterona. El 71,8% de los pacientes fueron mujeres y el 93% se diagnosticaron grado I según la OMS. Con respecto a la clasificacion histologica, los subtipos mas frecuentes fueron: Meningotelial (28%), fibroso (25%) y transicional (25%). El valor promedio de Ki67 fue 1,14 (0,11-10,71).
CONCLUSIÓN: Esta serie de casos mostró una mayor frecuencia en mujeres, con una alta expresión de receptores de progesterona y una baja tasa de proliferación de ki67. Estos datos se correlacionan con la literatura mundial. |
dc.format.extent | 30 |
dc.format.mimetype | application/pdf |
dc.language.iso | spa |
dc.rights | Derechos reservados - Universidad Nacional de Colombia |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.subject.ddc | 617 - Cirugía, medicina regional, odontología, oftalmología, otología, audiología |
dc.title | Caracterización de la expresión de receptores de progesterona en meningiomas intracraneales de pacientes tratados quirúrgicamente en una unidad de servicios de salud de alta complejidad en Bogotá – Colombia |
dc.type | Trabajo de grado - Especialidad Médica |
dc.rights.spa | Acceso abierto |
dc.type.driver | info:eu-repo/semantics/masterThesis |
dc.type.version | info:eu-repo/semantics/acceptedVersion |
dc.publisher.program | Bogotá - Medicina - Especialidad en Neurocirugía |
dc.description.degreelevel | Especialidades Médicas |
dc.publisher.branch | Universidad Nacional de Colombia - Sede Bogotá |
dc.relation.references | Wang N, Osswald M: Meningiomas: overview and new directions in therapy . Semin Neurol. 2018, 38:112-
120. 10.1055/s-0038-1636502 |
dc.relation.references | Marosi C, Hassler M, Roessler K, Reni M, Sant M, Mazza E, Vecht C: Meningioma. Crit Rev Oncol Hematol.
2008, 67:153-171. 10.1016/j.critrevonc.2008.01.010 |
dc.relation.references | Alexiou GA, Gogou P, Markoula S, Kyritsis AP: Management of meningiomas. Clin Neurol Neurosurg. 2010,
112:177-182. 10.1016/j.clineuro.2009.12.011 |
dc.relation.references | Longstreth WT Jr, Dennis LK, McGuire VM, Drangsholt MT, Koepsell TD: Epidemiology of intracranial
meningioma. Cancer. 1993, 72:639-648. 10.1002/1097-0142(19930801)72:3<639::aidcncr2820720304>
3.0.co;2-p |
dc.relation.references | Bondy M, Ligon BL: Epidemiology and etiology of intracranial meningiomas: a review . J Neuro-Oncol. 1996,
29:197-205. 10.1007/BF00165649 |
dc.relation.references | Buerki RA, Horbinski CM, Kruser T, Horowitz PM, James CD, Lukas RV: An overview of meningiomas.
Future Oncol. 2018, 14:2161-2177. 10.2217/fon-2018-0006 |
dc.relation.references | Sanson M, Cornu P: Biology of meningiomas. Acta Neurochir. 2000, 142:493-505. 10.1007/s007010050462 |
dc.relation.references | Shibuya M: Pathology and molecular genetics of meningioma: recent advances . Neurol Med Chir (Tokyo).
2015, 55:14-27. 10.2176/nmc.ra.2014-0233 |
dc.relation.references | Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC: "Malignancy" in meningiomas. A
clinicopathologic study of 116 patients, with grading implications. Cancer. 1999, 85:2046-2056.
10.1002/(sici)1097-0142(19990501)85:9<2046::aid-cncr23>3.0.co;2-m |
dc.relation.references | Hale AT, Wang L, Strother MK, Chambless LB: Differentiating meningioma grade by imaging features on
magnetic resonance imaging. J Clin Neurosci. 2018, 48:71-75. 10.1016/j.jocn.2017.11.013 |
dc.relation.references | Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM: Meningioma grading. An analysis of histologic
parameters. Am J Surg Pathol. 1997, 21:1455-1465. 10.1097/00000478-199712000-00008 |
dc.relation.references | Euskirchen P, Peyre M: Management of meningioma . Presse Med. 2018, 47:245-252.
10.1016/j.lpm.2018.05.016 |
dc.relation.references | Wilson CB: Meningiomas: genetics, malignancy, and the role of radiation in induction and treatment. The
Richard C Schneider Lecture. J Neurosurg. 1994, 81:666-675. 10.3171/jns.1994.81.5.0666 |
dc.relation.references | Nakano T, Asano K, Miura H, Itoh S, Suzuki S: Meningiomas with brain edema: radiological characteristics
on MRI and review of the literature. Clin Imaging. 2002, 26:243-249. 10.1016/s0899-7071(02)00433-3 |
dc.relation.references | Rohringer M, Sutherland GR, Louw DF, Sima AA: Incidence and clinicopathological features of meningioma .
J Neurosurg. 1989, 71:665-672. 10.3171/jns.1989.71.5.0665 |
dc.relation.references | Jaaskelainen J, Haltia M, Laasonen E, Wahlstrom T, Valtonen S: The growth rate of intracranial
meningiomas and its relation to histology. An analysis of 43 patients. Surg Neurol. 1985, 24:165-172.
10.1016/0090-3019(85)90180-6 |
dc.relation.references | Hsu DW, Efird JT, Hedley-Whyte ET: Progesterone and estrogen receptors in meningiomas: prognostic
considerations. J Neurosurg. 1997, 86:113-120. 10.3171/jns.1997.86.1.0113 |
dc.relation.references | Schneider B, Pulhorn H, Rohrig B, Rainov NG: Predisposing conditions and risk factors for development of
symptomatic meningioma in adults. Cancer Detect Prev. 2005, 29:440-447. 10.1016/j.cdp.2005.07.002 |
dc.relation.references | Inoue T, Akahira J, Suzuki T, Darnel AD, Kaneko C, Takahashi K: Progesterone production and actions in
the human central nervous system and neurogenic tumors. J Clin Endocrinol Metab. 2002, 87:5325-5331.
10.1210/jc.2002-012096 |
dc.relation.references | Korhonen K, Salminen T, Raitanen J, Auvinen A, Isola J, Haapasalo H: Female predominance in
meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor
expression. J Neuro-Oncol. 2006, 80:1-7. 10.1007/s11060-006-9146-9 |
dc.relation.references | Shaikh N, Dixit K, Raizer J: Recent advances in managing/understanding meningioma . F1000Res. 2018,
7:490. 10.12688/f1000research.13674.1 |
dc.relation.references | Alahmadi H, Croul SE: Pathology and genetics of meningiomas. Semin Diagn Pathol. 2011, 28:314-324.
10.1053/j.semdp.2011.01.002 |
dc.relation.references | Chamberlain MC, Blumenthal DT: Intracranial meningiomas: diagnosis and treatment . Expert review of
neurotherapeutics. 2004, 4:641-648. 10.1586/14737175.4.4.641 |
dc.relation.references | Sun C, Dou Z, Wu J, Jiang B, Iranmanesh Y, Yu X: The preferred locations of meningioma according to
different biological characteristics based on voxel-wise analysis. Front Oncol. 2020, 10:1412.
10.3389/fonc.2020.01412 |
dc.relation.references | De Monte F: Current management of meningiomas. Oncology (Williston Park). Park, 1995:83-91. |
dc.relation.references | Maiuri F, Mariniello G, Guadagno E, Barbato M, Corvino S, Del Basso De Caro M: WHO grade, proliferation
index, and progesterone receptor expression are different according to the location of meningioma. Acta
Neurochir (Wien). 2019, 161:2553-2561. 10.1007/s00701-019-04084-z |
dc.relation.references | Rockhill J, Mrugala M, Chamberlain MC: Intracranial meningiomas: an overview of diagnosis and treatment .
Neurosurg Focus. 2007, 23:E1. 10.3171/FOC-07/10/E1 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |
dc.subject.proposal | Ki67 |
dc.subject.proposal | Receptor de progesterona |
dc.subject.proposal | Progesterone receptor |
dc.subject.proposal | Meningioma |
dc.subject.proposal | Meningioma |
dc.subject.proposal | Ki67 |
dc.type.coar | http://purl.org/coar/resource_type/c_bdcc |
dc.type.coarversion | http://purl.org/coar/version/c_ab4af688f83e57aa |
dc.type.content | Text |
oaire.accessrights | http://purl.org/coar/access_right/c_abf2 |